🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To investigate the efficacy and safety of zolpidem for pediatric insomniacs...
Status
Completed
Location
Multiple Locations
Start Date
2007-02
Trial ID
NCT00432198
Treatments Being Tested
This study will evaluate the motor and cognitive benefits of low-dose zolpi...
Status
Completed
Location
University Hospitals Birmingham NHS Foundation Trust
Start Date
2018-08-20
Trial ID
NCT03621046
A double blind, randomized, placebo-controlled study will be conducted in c...
Status
Unknown
Location
Hospital São Paulo
Start Date
2013-07
Trial ID
NCT01920334
Treatments Being Tested
This study has been designed to compare the effects of melatonin with those...
Status
Completed
Location
Surrey CRC, University of Surrey, Egerton Road
Start Date
2009-07
Trial ID
NCT00940550
Investigation of Psychomotor and Cognitive Residual Effects of Single Oral ...
Status
Completed
Location
Sanofi-Aventis
Start Date
2006-01
Trial ID
NCT00283790
Treatments Being Tested
This will be a multi-center, randomized, blinded, comparative, placebo-cont...
Status
Terminated
Location
Broward Research Group
Start Date
2008-05
Trial ID
NCT00683436
Prior research has identified profound sleep disruption in individuals with...
Status
Completed
Location
University of California- San Francisco
Start Date
2019-06-02
Trial ID
NCT04014387
Treatments Being Tested
Obstructive sleep apnea (OSA) is a sleep disorder characterized by a cessat...
Status
Unknown
Location
Multiple Locations
Start Date
2023-10-15
Trial ID
NCT06084130
E2006-A001-108 is a 4-period crossover study designed to demonstrate that t...
Status
Completed
Location
NeuroTrials Research, Inc
Start Date
2016-11-21
Trial ID
NCT03008447
The primary objective is to evaluate the hypnotic efficacy of zolpidem-MR (...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2003-09
Trial ID
NCT00630175
Treatments Being Tested